logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Istituto Cardiocentro Ticino

+41918115111
echo3d@cardiocentro.org
Source: Site record.
https://www.cardiocentro.org

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Fully integrated into the public healthcare system of the Ente Ospedaliero Cantonale since January 1, 2021, Cardiocentro Ticino was established as a private foundation in 1995 at the initiative of its financial backer, Dr. Eduard Zwick, and thanks to the tireless and forward-looking commitment of Prof. Tiziano Moccetti, who led the institution for more than twenty years following its inauguration on July 1, 1999.Today, Cardiocentro is not only an essential healthcare center in the region for the prevention and treatment of heart disease, but also an internationally renowned institution, actively involved in research and strongly committed to education and training. It maintains important and ongoing medical and scientific collaborations with renowned universities and research institutes in Switzerland...

Business Status

Source: Google. OPEN

Business Category

Source: Google. Heart hospital

Business Subcategory

Source: Google. Heart hospital
Source: Trial-derived.
12Total Trials
Source: Trial-derived.
5Recruiting Trials
Source: Trial-derived.
7Active Trials
Source: Trial-derived.
4Completed Trials
Source: Trial-derived.
25Unique Conditions
Source: Trial-derived.
12Unique Sponsors

Conditions

Source: Trial-derived. Antiplatelet Therapy (2)Source: Trial-derived. Arrythmia (2)Source: Trial-derived. Atrial Fibrillation (AF) (2)Source: Trial-derived. Coronary Artery Disease (2)Source: Trial-derived. Hypertension (2)Source: Trial-derived. Acute Coronary Syndrome (ACS) (1)Source: Trial-derived. Acute Coronary Syndromes (1)Source: Trial-derived. Atrial Fibrillation (1)

Sponsors

Source: Trial-derived. Cardiocentro Ticino (3)Source: Trial-derived. Biotronik SE & Co. KG (1)Source: Trial-derived. Boehringer Ingelheim (1)Source: Trial-derived. Boston Scientific Corporation (1)Source: Trial-derived. EBR Systems, Inc. (1)Source: Trial-derived. EPD Solutions, A Philips Company (1)Source: Trial-derived. Insel Gruppe AG, University Hospital Bern (1)Source: Trial-derived. Medtronic (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Cardiac device interrogation and programming
Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures
Source: AI-inferred. Cardiac implantable electronic device implantation

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. 24-hour ambulatory blood pressure monitoring
Source: AI-inferred. Cardiac catheter ablation
Source: AI-inferred. Cardiac electroanatomic mapping